Thermo Fisher Scientific Inc [TMO] stock is trading at $400.48, up 0.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TMO shares have lost -1.10% over the last week, with a monthly amount drifted -7.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Thermo Fisher Scientific Inc [NYSE: TMO] stock has seen the most recent analyst activity on January 10, 2025, when Bernstein upgraded its rating to a Outperform but kept the price target unchanged to $630 for it. On October 14, 2024, Redburn Atlantic initiated with a Buy rating. Stephens started tracking the stock assigning a Overweight rating and suggested a price target of $680 on October 01, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $670 as its price target on August 28, 2024.
Thermo Fisher Scientific Inc [TMO] stock has fluctuated between $390.49 and $627.88 over the past year. Currently, Wall Street analysts expect the stock to reach $623.25 within the next 12 months. Thermo Fisher Scientific Inc [NYSE: TMO] shares were valued at $400.48 at the most recent close of the market. An investor can expect a potential return of 55.63% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Thermo Fisher Scientific Inc [NYSE:TMO] reported sales of 42.90B for the trailing twelve months, which represents a growth of 0.18%. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.13 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 395.61 points at the first support level, and at 390.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 403.54, and for the 2nd resistance point, it is at 406.61.
Ratios To Look Out For
For context, Thermo Fisher Scientific Inc’s Current Ratio is 1.77. In addition, the Quick Ratio stands at 1.38 and the Cash Ratio stands at 0.31. Considering the valuation of this stock, the price to sales ratio is 3.52, the price to book ratio is 3.06 and price to earnings (TTM) ratio is 23.50.
Transactions by insiders
Recent insider trading involved Pettiti Gianluca, Executive Vice President, that happened on May 12 ’25 when 400.0 shares were sold. Officer, Pettiti Gianluca completed a deal on May 12 ’25 to buy 400.0 shares. Meanwhile, Executive Vice President Pettiti Gianluca sold 300.0 shares on Apr 28 ’25.
